相关实验视频

Updated: Jul 15, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

在ICU中感染性败血症患者的细菌病:有什么不同?

Tomáš Nejtek^1,2, Martin Müller², Michal Moravec^1,2

¹Department of Epidemiology, Faculty of Military Science, University of Defence, 500 01 Hradec Králové, Czech Republic.

|September 28, 2023

概括

败血症患者的细菌病 (血液中的细菌) 可能与感染源和先前使用抗生素有关. 虽然细菌病在统计学上并不显著,但其死亡率较高,在重症监护室 (ICU) 停留时间较长的趋势是显著的.

科学领域:

* 关键护理医学关键护理医学
* 传染病传染病
* 临床微生物学临床微生物学

背景情况:

* 败血症和败血性休克是全球主要的死亡原因.
* 败血症患者的细菌病的临床影响仍然不完全理解.
*了解细菌病的作用对于改善败血症管理至关重要.

研究的目的:

* 为了比较有和没有细菌血症的败血症患者的临床特征和结果.
* 确定影响细菌性与非细菌性败血症死亡率的因素.
* 探索细菌病,感染部位和先前治疗之间的关系.

主要方法:

*对258名在重症监护室 (ICU) 接受治疗的败血症患者的回顾性分析.
*根据细菌病的存在或不存在对患者队列进行比较.
*多变量分析以评估死亡率预测因素,包括查尔森并发症指数 (CCI).

主要成果:

* 在没有先前接受抗生素治疗的患者中,细菌病更为常见.
* 感染性内心炎,导管相关和软组织感染的细菌病率高于呼吸道败血症.
* 增加的临床严重程度和更高的CCI显著影响了死亡率.
* 细菌病趋向于更高的死亡率和更长的ICU停留时间,但缺乏统计学意义.

结论:

* 败血症中的细菌性与特定的感染源和先前的抗生素暴露有关.
* 临床严重程度和并发症是败血症死亡率的关键决定因素.
*虽然细菌病可能表明预后更差,但需要进一步的研究来确认其对死亡率和ICU停留时间的独立影响.

关键词:

在ICU中,医生会对患者进行治疗.败血症-3 这种疾病.细菌病的细菌病是什么意思感染的焦点感染的焦点.结果结果结果结果.这是一种血症.败血症的冲击是一个令人震惊的现象.

更多相关视频

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

相关概念视频

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Urinary Tract Infection II: Pathophysiology

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Urine Studies II: Urine Culture and Sensitivity Test

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: